Literature DB >> 932209

An assessment of daily production and significance of thyroidal secretion of 3, 3', 5'-triiodothyronine (reverse T3) in man.

I J Chopra.   

Abstract

While 3, 3', 5'-triiodothyronine (reverse T3, rT3) has been detected both in human serum and in thyroglobulin, no quantitative assessment of its metabolic clearance rate (MCR), production rate (PR), or secretion by the thyroid is yet available. This study examines this information in euthyroid subjects and evaluates it in light of similar information about two other iodothyronines in the thyroid: 3, 5, 3'-triiodothyronine (T3) and thyroxine (T4). Thus, it was noted that rT3 is cleared from human serum at a much faster rate than are T3 and T4; the mean (+/-SE) MCR of rT3 was 76.7+/-5.4 liters/day in 10 subjects, whereas MCR-T3 and MCR-T4 in 8 of them were 26.0+/-2.2 liters/day and 1.02+/-0.06 liters/day, respectively. Therefore, even though the mean serum concentration of rT3, 48+/-2.8 ng/100 ml, was much lower than that (128+/-6.7 ng/100 ml) of T3, the mean PR-rT3 (36.5+/-2.8 mug/day) and the mean PR-T3 (33.5+/-3.7 mug/day) were similar; in comparison, the mean serum concentration and PR of T4 were 8.6+/-0.5 mug/100 ml and 87.0+/-3.9 mug/day, respecitvely. These data and those on the relative proportion of rT3, T3, and T4 in 10 thyroid glands were used to assess the significance of the contribution of thyroidal secretion to PR-rT3 and PR-T3. It was estimated that whereas thyroidal secretion may account for about 23.8% of serum T3 (or PR-T3), it may account for only about 2.5% of serum rT3 (or PR-rT3). Since peripheral metabolism of T4 is the only known source of rT3 and T3 other than the thyroidal secretion, it could be calculated that as much as 73.0 mug or 84% of daily PR-T4 may normally be metabolized by monodeiodination either to T3 or to rT3. MCR and PR of various iodothyronines were also examined in five cases with hepatic cirrhosis, where, as documented previously, serum rT3 may be elevated while serum T3 is diminished. The mean MCR-rT3 in these cases (41.0 liters/day) was clearly (P is less than 0.005) less than that (76.7 liters/day) in normal subjects. This was the case at a time when the mean MCR-T3 (26.7 liters/day) and the mean MCR-T4 (1.19 liters/day) did not differ from those (vide supra) in normal subjects. Distinct from changes in MCRs, the mean PR-rT3 (33.0 mug/day) was similar to, and the mean PR-T3 (10.1 mug/day) and the mean PR-T4 (66.4 mug/day) were much less than, the corresponding value in normal subjects. Furthermore, while the ratio of PR-rT3 and PR-T4 (rT3/T4) in individual patients was either supranormal or normal, the ratio of PR-T3 and PR-T4 (T3/T4) was clearly subnormal. The various data suggest that: (a) just as in the case of T3, the thyroid gland is a relatively minor source of rT3; peripheral metabolism of T4 is apparently its major source; (b) the bulk of T4 metabolized daily is monodeiodinated to T3 or to rT3; (c) monodeiodination may be an obligatory step in metabolism of T4; (d) monodeiodination of T4 to rT3 is maintained normal or is increased in hepatic cirrhosis at a time when monodeiodination of T4 to T3 is decreased.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 932209      PMCID: PMC333152          DOI: 10.1172/JCI108456

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

Review 1.  Active form of the thyroid hormone.

Authors:  S H Ingbar; L E Braverman
Journal:  Annu Rev Med       Date:  1975       Impact factor: 13.739

2.  Letter: (to the editor). Erratum: revised calculations of common parameters of iodothyronine metabolism and distribution by noncompartmental analysis.

Authors:  J H Oppenheimer; H L Schwartz; M I Surks
Journal:  J Clin Endocrinol Metab       Date:  1975-12       Impact factor: 5.958

3.  Diversion of peripheral thyroxine metabolism from activating to inactivating pathways during complete fasting.

Authors:  A G Vagenakis; A Burger; G I Portnary; M Rudolph; J R O'Brian; F Azizi; R A Arky; P Nicod; S H Ingbar; L E Braverman
Journal:  J Clin Endocrinol Metab       Date:  1975-07       Impact factor: 5.958

4.  An improved radioimmunoassay of triiodothyronine in serum: its application to clinical and physiological studies.

Authors:  I J Chopra; R S Ho; R Lam
Journal:  J Lab Clin Med       Date:  1972-11

5.  The influence of liver damage in man on the distribution and disposal rates of thyroxine and triiodothyronine.

Authors:  J McConnon; V V Row; R Volpé
Journal:  J Clin Endocrinol Metab       Date:  1972-01       Impact factor: 5.958

6.  Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).

Authors:  I J Chopra; D E Williams; J Orgiazzi; D H Solomon
Journal:  J Clin Endocrinol Metab       Date:  1975-11       Impact factor: 5.958

7.  Reciprocal changes in serum concentrations of 3,3',5-triiodothyronine (T3) in systemic illnesses.

Authors:  I J Chopra; U Chopra; S R Smith; M Reza; D H Solomon
Journal:  J Clin Endocrinol Metab       Date:  1975-12       Impact factor: 5.958

8.  Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man.

Authors:  J T Nicoloff; J C Low; J H Dussault; D A Fisher
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

9.  Effects of replacement doses of sodium L-thyroxine on the peripheral metabolism of thyroxine and triiodothyronine in man.

Authors:  L E Braverman; A Vagenakis; P Downs; A E Foster; K Sterling; S H Ingbar
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

10.  A radioimmunoassay for measurement of 3,3',5'-triiodothyronine (reverse T3).

Authors:  I J Chopra
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

View more
  42 in total

1.  Birmingham Medical Research Expeditionary Society 1977 Expediton: thyroid function and acute mountain sickenss.

Authors:  A D Wright
Journal:  Postgrad Med J       Date:  1979-07       Impact factor: 2.401

Review 2.  Reawakened interest in type III iodothyronine deiodinase in critical illness and injury.

Authors:  Stephen A Huang; Antonio C Bianco
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-01-22

Review 3.  Hormonal changes in non-endocrine disease.

Authors:  C G Semple
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

4.  Serum thyroid hormone levels in patients with fulminant hepatitis: usefulness of rT3 and the rT3/T3 ratio as prognostic indices.

Authors:  T Kano; T Kojima; T Takahashi; Y Muto
Journal:  Gastroenterol Jpn       Date:  1987-06

5.  Observations on the factors that control the generation of triiodothyronine from thyroxine in rat liver and the nature of the defect induced by fasting.

Authors:  A Balsam; S H Ingbar
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

6.  The effect of iodothyronines on the conversion of thyroxine into 3,3'-5-tri-iodothyronine in isolated rat renal tubules.

Authors:  P Heyma; R G Larkins; D G Campbell
Journal:  Biochem J       Date:  1980-08-15       Impact factor: 3.857

Review 7.  Thyroid disease in older patients. Diagnosis and treatment.

Authors:  P Finucane; C Anderson
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

8.  Development of thyroid function between VI-IX month of fetal life in humans.

Authors:  A Costa; V De Filippis; M Panizzo; G Giraudi; E Bertino; R Arisio; M Mostert; G Trapani; C Fabris
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

9.  3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man.

Authors:  L A Gavin; M E Hammond; J N Castle; R R Cavalieri
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

10.  L-triiodothyronine and L-reverse-triiodothyronine generation in the human polymorphonuclear leukocyte.

Authors:  K A Woeber
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.